Tower View Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Tower View Wealth Management's EW Position: Q2 2022 in Review
Tower View Wealth Management sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 42,490 shares — an estimated $5M sold.
Tower View Wealth Management first reported a position in EW in Q4 2017 and held it in 18 quarters. The position peaked at $5.45M in Q4 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.
- Tower View Wealth Management reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
- Tower View Wealth Management sold 42,490 Edwards Lifesciences shares in Q2 2022, an estimated $5M.
- Tower View Wealth Management first reported a position in Edwards Lifesciences in Q4 2017 and held it in 18 quarters.
- Tower View Wealth Management's Edwards Lifesciences position peaked at $5.45M in Q4 2021.
- 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.
Based on Tower View Wealth Management's 13F filing for Q2 2022, filed 8 Aug 2022.